張雨辰 許明 劉瓊 胡碧濃 唐麗亞 艾坤 張泓
〔摘要〕 目的 通過(guò)觀察電針對(duì)急性期骶上脊髓損傷(suprasacral cord injury, SSCI)后逼尿肌-括約肌協(xié)同失調(diào)(detrusor sphincter dyscoordination, DSD)大鼠膀胱最大容量(maximum cystometric capacity, MCC)、漏尿點(diǎn)壓力(leakage point pressure, LPP)、血清尿素氮(blood urea nitrogen, BUN)、血肌酐(serum creatinine, SCR)和腎組織形態(tài)學(xué)的改變,探討電針治療在SSCI急性期對(duì)上、下尿路功能(膀胱功能和腎功能)的影響。方法 36只SD雌性大鼠,隨機(jī)抽取12只作為空白組,剩余24只采用改良Hassan Shaker脊髓橫斷法在T10脊髓節(jié)段全橫斷制作SSCI大鼠模型,成模后隨機(jī)分為模型組和電針組,每組12只。電針組取“次髎”“中極”“三陰交”穴予持續(xù)電針刺激40 min,1次/d,連續(xù)治療7 d;空白組與模型組只捆綁不治療。采用膀胱造瘺法進(jìn)行尿流動(dòng)力學(xué)檢測(cè);隨后腹主動(dòng)脈采血,通過(guò)SCR、BUN檢測(cè)評(píng)估腎功能;處死大鼠后取腎行HE染色,觀察其組織形態(tài)結(jié)構(gòu)的變化。結(jié)果 與空白組比,模型組大鼠MCC、LPP、BUN和SCR均顯著升高(P<0.01);電針組大鼠MCC、BUN和SCR顯著低于模型組(P<0.01),高于空白組(P<0.05或P<0.01);電針組大鼠LPP顯著低于模型組(P<0.01),較空白組差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05)。與模型組相比,電針組大鼠腎皮質(zhì)炎性細(xì)胞浸潤(rùn)減輕、胞質(zhì)空泡化減少,皮質(zhì)部集合小管和腎小管上皮細(xì)胞核固縮減輕,腎小管壞死減少。結(jié)論 電針治療可能通過(guò)降低SSCI后DSD大鼠MCC和LPP以改善腎臟微血管血流,發(fā)揮對(duì)腎功能和腎臟結(jié)構(gòu)的保護(hù)作用。電針穴位可能刺激骶神經(jīng)、脛神經(jīng)的神經(jīng)傳入,促進(jìn)尿道外括約肌爆發(fā)恢復(fù),并且通過(guò)調(diào)節(jié)交感、副交感神經(jīng)傳出而影響排尿效率。
〔關(guān)鍵詞〕 骶上脊髓損傷;逼尿肌-括約肌協(xié)同失調(diào);尿道外括約肌爆發(fā)模式;膀胱順應(yīng)性;上尿路損傷;腎臟微血管血流;腎功能
〔中圖分類號(hào)〕R245;R694 ? ? ? 〔文獻(xiàn)標(biāo)志碼〕A ? ? ? ?〔文章編號(hào)〕doi:10.3969/j.issn.1674-070X.2023.03.020
Effects of electroacupuncture on renal and lower urinary tract function of rats in the
acute stage of suprasacral spinal cord injury
ZHANG Yuchen, XU Ming, LIU Qiong, HU Binong, TANG Liya, AI Kun*, ZHANG Hong*
College of Acupuncture & Tuina and Rehabilitation, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China
〔Abstract〕 Objective To investigate the effects of electroacupuncture on upper and lower urinary tract function (bladder function and renal function) in the acute stage of suprasacral cord injury (SSCI), by observing the changes of maximum cystometric capacity (MCC), leakage point pressure (LPP), blood urea nitrogen (BUN), serum creatinine (SCR) and renal histopathology in rats with detrusor sphincter dyscoordination (DSD) after SSCI. Methods There were 36 SD female rats, 12 of which were randomly selected as control group. The remaining 24 rats were made into SSCI models by modified Hassan Shaker spinal cord transection at T10 segment, which were randomized into model group and electroacupuncture group, with 12 rats in each. In electroacupuncture group, points of Ciliao (BL32), Zhongji (CV3) and Sanyinjiao (SP6) were subjected to continuous electroacupuncture stimulation for 40 min, once per day, for consecutive 7 d; control group and model group were only bound without any treatment. The urodynamic test was performed by cystostomy. Then, blood samples were collected from the abdominal aortas, and SCR and BUN were detected to evaluate the renal function. After the rats were sacrificed, the kidneys were stained with HE to observe the changes of histomorphology and structural injury. Results Compared with control group, MCC, LPP, BUN and SCR in model group ?significantly increased (P<0.01). MCC, BUN and SCR in the electroacupuncture group were significantly lower than those in the model group (P<0.01), but higher than those in the control group (P<0.05 or P<0.01). LPP of the electroacupuncture group was significantly lower than that of the model group (P<0.01), but there was no statistical significance compared with the control group (P>0.05). Compared with the model group, the inflammatory cell infiltration and cytoplasmic vacuolation of the renal cortex were reduced, karyopyknosis of the epithelia of the collecting tubules and renal tubules were improved and the renal tubule necrosis decreased in electroacupuncture group. Conclusion Electroacupuncture may reduce MCC and LPP of DSD rats after SSCI to improve renal microvascular blood flow and play a protective role in renal function and renal structure. It may promote the recovery of external urethral sphincter bursting activity by stimulating the afference of the sacral and tibial nerves through the selected points, and affect the efficiency of urination by regulating the efference of the sympathetic and parasympathetic nerves.
〔Keywords〕 suprasacral cord injury; detrusor sphincter dyscoordination; external urethral sphincter bursting activity; bladder compliance; upper urinary tract injury; renal microvascular blood flow; renal function
脊髓損傷(spinal cord injure, SCI)可影響感覺、運(yùn)動(dòng)和自主神經(jīng)系統(tǒng)功能,而神經(jīng)源性膀胱(neurogenic bladder, NB)是SCI常見的繼發(fā)性并發(fā)癥,發(fā)病率高并極大地影響患者的生活質(zhì)量[1]。SCI患者NB的表現(xiàn)取決于損傷的位置。鑒于脊髓對(duì)排尿的控制發(fā)生在S2~S4骶叢節(jié)段,當(dāng)病變位于S2~S4(脊髓圓錐、馬尾或周圍神經(jīng))以上的節(jié)段,則為骶上脊髓損傷(suprasacral cord injury, SSCI)[2]。
SSCI造成上運(yùn)動(dòng)神經(jīng)元病變,導(dǎo)致逼尿肌和外括約肌同時(shí)過(guò)度活躍。由此產(chǎn)生的排尿障礙會(huì)導(dǎo)致尿液回流到輸尿管和腎臟,最終增加患者尿路感染及腎臟疾病的患病風(fēng)險(xiǎn)[3]。有研究稱,70%~84%的SCI患者在一生中的某個(gè)階段會(huì)出現(xiàn)NB[4],如果不治療可能會(huì)隨著時(shí)間的推移導(dǎo)致腎功能惡化、腎結(jié)石、難治性尿失禁和惡性腫瘤等[5]。
慢性SCI患者會(huì)出現(xiàn)腎功能障礙,且損傷早期影響腎功能的因素也很多。嚴(yán)重SCI早期已出現(xiàn)腎功能損害,且高位損傷造成的腎功能不全比低位損傷更明顯,這證明SSCI患者急性期的腎功能保護(hù)的重要性。針灸作為該病的有效治療手段[6],能否通過(guò)改善下尿路功能阻止SSCI早期的腎功能損害,值得進(jìn)一步探究。
1 材料與方法
1.1 ?實(shí)驗(yàn)動(dòng)物
雌性SD成年大鼠36只,SPF級(jí),體質(zhì)量230~250 g。湖南中醫(yī)藥大學(xué)動(dòng)物實(shí)驗(yàn)中心提供,許可證號(hào):SCXK(湘)2019-0004,合格證號(hào):1107271911006889。分籠飼養(yǎng)于湖南中醫(yī)藥大學(xué)動(dòng)物中心實(shí)驗(yàn)室,飼養(yǎng)溫度24~26 ℃,濕度 50%~70%。實(shí)驗(yàn)單位使用許可證號(hào):SYXK(湘)2019-0009,倫理證明號(hào):LL2019092303。
1.2 ?主要試劑、藥物和儀器
10%水合氯醛溶液(國(guó)藥集團(tuán)化學(xué)試劑有限公司,10 mL,批號(hào):20181120);青霉素鈉(華北制藥集團(tuán)有限責(zé)任公司,80萬(wàn)U,批號(hào):H13020657);伊紅染液、蘇木素染液(武漢塞維爾生物科技有限公司,批號(hào):CR1901064);象皮生肌膏(湖南中醫(yī)藥大學(xué)第一附屬醫(yī)院藥劑科自制);苦蘋果防舔防咬噴劑(美國(guó)Grannick公司,236 mL)。
導(dǎo)尿管(上海上醫(yī)康鴿醫(yī)用器材有限責(zé)任公司,型號(hào):F3);針灸針(蘇州天一針灸器械有限公司,型號(hào):0.25 mm×25 mm、0.25 mm×13 mm);電針治療儀(蘇州醫(yī)療用品廠有限公司,型號(hào):SDZ-V);MP-150多通道生理記錄儀(美國(guó)BIOPAC公司,型號(hào):MP150-WSW);雙通道微量注射泵(浙江史密斯醫(yī)學(xué)儀器有限公司,型號(hào):WZ-50C6);生物顯微鏡、數(shù)碼醫(yī)學(xué)圖像分析系統(tǒng)(麥克奧迪實(shí)業(yè)集團(tuán)有限公司,型號(hào):BA410、Med 6.0);低溫離心機(jī)(美國(guó)SCILOGEX公司,型號(hào):D3024R);全自動(dòng)生化分析儀(日本東芝,型號(hào):TBA-120FR)等。
1.3 ?動(dòng)物分組與造模
1.3.1 ?分組 ?36只大鼠隨機(jī)編號(hào)后,采用隨機(jī)數(shù)字表法分組。首先選取12只作為空白組,其余24只大鼠在T10脊髓節(jié)段采用改良Hassan Shaker脊髓橫斷法[7]制作完全性SSCI模型,成模后再分為模型組和電針組,每組12只。
1.3.2 ?造模方法 ?大鼠術(shù)前24 h禁食不禁水,術(shù)前2 h腹腔注射20萬(wàn)U青霉素鈉預(yù)防感染。稱重后,用10%水合氯醛300 mg/kg行腹腔麻醉,隨后將大鼠俯臥固定于鼠板上備皮。采用改良Hassan Shaker脊髓橫斷法制作完全性SSCI模型。脊髓橫斷部位選取T10脊髓節(jié)段(相當(dāng)于T8椎骨的位置),通過(guò)浮肋連接的T13作為骨性標(biāo)志向上進(jìn)行具體定位。確定手術(shù)部位后做標(biāo)記并消毒皮膚,以標(biāo)記點(diǎn)為中心沿背部正中線作長(zhǎng)約3 cm的縱向切口,依次切開表皮和皮下筋膜,使用玻璃分針鈍性分離兩側(cè)豎脊肌,充分暴露棘突和椎板。用顯微咬骨器從尾側(cè)向頭側(cè)咬除T8椎板直至兩側(cè)椎弓根,使脊髓充分暴露,用牙科鉤沿橫斷椎間隙橫向小幅度鉤出脊髓,手術(shù)刀切斷脊髓后反復(fù)刮掃以確定脊髓完全橫斷,確定無(wú)神經(jīng)纖維殘留,則表明脊髓完全橫斷[8]。最后由內(nèi)向外逐層縫合完成手術(shù)。手術(shù)全程要求嚴(yán)格消毒及無(wú)菌操作,術(shù)后觀察大鼠的生命體征是否平穩(wěn)。
1.4 ?術(shù)后護(hù)理
(1)體溫管理:術(shù)后立即置于電熱毯上防止體溫過(guò)低,以肛溫計(jì)上升到 37 ℃以上為佳,大鼠均單籠飼養(yǎng)。(2)抗感染護(hù)理:術(shù)后48 h內(nèi),腹腔注射青霉素鈉20萬(wàn)U/12 h;48 h后至術(shù)后7 d,20萬(wàn)U/24 h;從術(shù)后第8天開始,如大鼠出現(xiàn)膿尿、血尿,則注射20萬(wàn)U/24 h以抗感染,直至尿液澄清。術(shù)后每24 h在傷口周圍使用碘酊進(jìn)行皮膚消毒3次。(3)Crede手法排尿:每8 h(早、中、晚)用Crede法對(duì)大鼠進(jìn)行人工輔助排尿,注意手法和力度,防止損傷膀胱。密切觀察大鼠的生命體征,每日總飲水量小于30 mL,防止因膀胱大量尿潴留導(dǎo)致腎臟及膀胱壁損傷。(4)壓瘡防護(hù):用50%乙醇溶液擦拭大鼠的身體(腹部及雙下肢)以防止壓瘡;有壓瘡形成時(shí)用象皮生肌膏涂抹以促進(jìn)傷口愈合。(5)自殘防護(hù):因術(shù)后大鼠下肢感覺缺失,部分老鼠會(huì)出現(xiàn)撕咬手術(shù)部位和下肢的自殘行為,可涂上苦蘋果防舔防咬噴劑以防止自殘。
1.5 ?納入及剔除標(biāo)準(zhǔn)
1.5.1 ?納入標(biāo)準(zhǔn) ?(1)運(yùn)動(dòng)功能評(píng)估:采用BBB評(píng)分法[9],評(píng)估大鼠后肢運(yùn)動(dòng)功能恢復(fù)情況。0分為雙后肢拖行。(2)排尿功能評(píng)估:脊髓休克后,雖能不自主間斷的少許排尿,但膀胱內(nèi)仍潴留大量尿液,Crede手法輔助排尿時(shí)觸及脹大的膀胱在兩手拇指指腹間滾動(dòng)并感覺排尿有阻力。
同時(shí)滿足以上兩項(xiàng)條件“(1)BBB評(píng)分為0分”和“(2)采用Crede手法輔助排尿時(shí)感到阻力”,則認(rèn)為模型成功,納入實(shí)驗(yàn)。
1.5.2 ?剔除標(biāo)準(zhǔn) ?造模后大鼠出現(xiàn)雙后肢自主運(yùn)動(dòng),脊髓休克期后完全尿潴留或自主排尿,大鼠自殘或死亡的情況,均予以剔除。
1.6 ?治療方案
1.6.1 ?處理方法 ?術(shù)后第14天開始實(shí)施干預(yù),電針組大鼠取“次髎”“中極”“三陰交”穴予持續(xù)電針刺激,空白組與模型組大鼠只捆綁固定,共40 min,1次/d,連續(xù)7 d。
1.6.2 ?取穴方法 ?參照“十三五”國(guó)家規(guī)劃統(tǒng)編教材《實(shí)驗(yàn)針灸學(xué)》[10]大鼠標(biāo)準(zhǔn)穴位圖譜定位,并模擬人體腧穴骨度分寸法量取“次髎”“中極”“三陰交”穴。
1.6.3 ?電針?lè)椒??(1)針刺方法:各穴均用30號(hào)1寸針直刺,深度分別為次髎15 mm、中極5 mm、三陰交5 mm。(2)穴位對(duì)接:大鼠仰臥位固定,中極與三陰交一組(三陰交左右兩穴隔日交替進(jìn)行);俯臥位固定,次髎與大鼠尾根部一組(次髎左右兩穴隔日交替進(jìn)行)。(3)電針刺激參數(shù):SDZ-V型華佗牌電針治療儀,疏密波10/50 Hz,強(qiáng)度以肢體輕顫并耐受為度,刺激時(shí)間20 min。
1.7 ?指標(biāo)檢測(cè)
1.7.1 ?尿流動(dòng)力學(xué)檢測(cè) ?治療7 d后,所有大鼠采用膀胱造瘺法行尿流動(dòng)力學(xué)檢測(cè)。大鼠麻醉后,用Crede手法排空膀胱后進(jìn)行膀胱造瘺,用眼科剪在膀胱頂部造一小口插入F3導(dǎo)尿管,深度1~2 cm,用4-0絲線將切口部位膀胱與導(dǎo)管捆綁固定防止?jié)B漏。將導(dǎo)尿管、MP150-WSW型16通道生理記錄儀與WZ-50C6微量注射泵通過(guò)三通管相連接。始終保持導(dǎo)尿管水平放置,與尿道平行,設(shè)置MP150主機(jī)壓力基線為零。打開微量注射泵,灌注速度為6 mL/h,灌注的生理鹽水溫度為25~35 ℃。觀察并記錄大鼠首次尿液溢出時(shí)的膀胱壓力即為漏尿點(diǎn)壓力(leakage point pressure, LPP),最大膀胱容量(maximum cystometric capacity, MCC)則為從開始灌注到尿液首次溢出期間所灌注的液體總量。
1.7.2 ?腎功能檢測(cè) ?尿流動(dòng)力學(xué)檢測(cè)完畢后,每組隨機(jī)抽取6只(共18只)進(jìn)行腹主動(dòng)脈采血,取滿5 mL動(dòng)脈血后將真空采血管靜置于低溫離心機(jī),最大離心半徑8.5 cm,3000 r/min,離心10 min,分離上層血清,全自動(dòng)生化分析儀檢測(cè)血清尿素氮(blood urea nitrogen, BUN)和血肌酐(serum creatinine, SCR)的含量以評(píng)估各組大鼠腎功能。
1.7.3 ?腎組織形態(tài)學(xué)觀察 ?大鼠采血后處死,取腎組織,將其浸泡于4%多聚甲醛溶液固定24 h,經(jīng)脫水、透明后制成蠟塊,再制成石蠟切片,采用蘇木精-伊紅(HE)染色后封片,分別置于40倍和200倍生物顯微鏡下觀察腎的組織形態(tài)學(xué)改變。所有圖片采用Motic Med 6.0數(shù)碼醫(yī)學(xué)圖像分析系統(tǒng)處理。
1.8 ?統(tǒng)計(jì)學(xué)方法
使用SPSS 22.0進(jìn)行數(shù)據(jù)處理。計(jì)量資料以“x±s”表示,所有資料均進(jìn)行正態(tài)性和方差齊性檢驗(yàn),符合正態(tài)分布者采用單因素方差分析;不符合正態(tài)分布者采用非參數(shù)檢驗(yàn)。均以P<0.05為差異有統(tǒng)計(jì)學(xué)意義。
2 結(jié)果
2.1 ?尿流動(dòng)力學(xué)檢測(cè)結(jié)果
模型組、電針組各1只大鼠因死亡剔除實(shí)驗(yàn),最后納入34只大鼠進(jìn)行尿流動(dòng)力學(xué)檢測(cè)。與空白組相比,模型組大鼠MCC和LPP顯著增大(P<0.01)。電針組大鼠MCC和LPP較模型組均顯著降低(P<0.01),且LPP較空白組差異無(wú)統(tǒng)計(jì)學(xué)意義(P>0.05),但MCC仍顯著高于空白組(P<0.01)。詳見表1。
2.2 ?腎功能檢測(cè)結(jié)果
與空白組相比,模型組大鼠BUN和SCR均顯著升高(P<0.01)。而電針組大鼠BUN和SCR顯著低于模型組(P<0.01),但高于空白組(P<0.05或P<0.01)。詳見表2。
2.3 ?腎組織形態(tài)學(xué)觀察結(jié)果
正常雌性大鼠腎皮質(zhì)層切片HE染色(見圖1A和A')顯示:腎皮質(zhì)由腎小體和腎小管組成。而腎小體是由毛細(xì)血管腎小球簇以及包繞在其外的Bowman囊構(gòu)成。囊的外壁層由單層扁平上皮構(gòu)成,與近球小管上皮細(xì)胞相連續(xù);內(nèi)層緊包在毛細(xì)血管袢的外面;兩層之間為腎小囊腔。腎小管分為近端小管和遠(yuǎn)端小管,近端小管管腔狹窄且不規(guī)則,而遠(yuǎn)端小管管腔清晰。偶見皮質(zhì)部集合小管,管壁由立方形上皮細(xì)胞構(gòu)成,胞質(zhì)色淡而明亮,細(xì)胞分界清楚,結(jié)構(gòu)簡(jiǎn)單。
SSCI大鼠(見圖1B和B')切片中可見:腎小球縮小,Bowman囊增厚,腎小囊腔間隙擴(kuò)大;腎小體間可見炎性細(xì)胞浸潤(rùn)。大量腎小管上皮細(xì)胞出現(xiàn)細(xì)胞核深染固縮、胞漿呈空泡狀,部分腎小管壞死。集合小管管腔擴(kuò)張,管壁上皮細(xì)胞出現(xiàn)深染的核固縮。
電針治療大鼠(圖1C和C')切片顯示:腎小體、近端小管和遠(yuǎn)端小管結(jié)構(gòu)基本保留,少量細(xì)胞出現(xiàn)固縮核或細(xì)胞質(zhì)空泡化,輕微炎性細(xì)胞浸潤(rùn)。
3 討論
尿路包括兩個(gè)相互依賴的組成部分:上尿路(腎臟、輸尿管)和下尿路(膀胱、尿道)。其作為一個(gè)功能單元,先將尿液從腎臟推進(jìn)到膀胱,再以低壓儲(chǔ)存在膀胱內(nèi),最終間歇性地將尿液經(jīng)尿道完全排出體外[11]。
理論上,SSCI后膀胱功能異常包括充盈期逼尿肌過(guò)度活動(dòng)(detrusor overactivity, DO),排尿期逼尿肌-括約肌協(xié)同失調(diào)(detrusor sphincter dyscoordination, DSD)。下尿路功能特征為:(1)膀胱充盈過(guò)程中出現(xiàn)非排尿收縮;(2)排尿效率降低;(3)殘余尿量增加;(4)膀胱容量增加[12]。實(shí)際上,不同程度的損傷可能導(dǎo)致不可預(yù)測(cè)的混合排尿功能障礙。尿動(dòng)力學(xué)檢測(cè)有助于早期辨別膀胱儲(chǔ)存能力和順應(yīng)性[13]。本研究T8椎體水平脊髓橫斷后,模型組大鼠膀胱MCC和LPP均顯著增大(P<0.01),說(shuō)明膀胱壓力高、排空效率低、膀胱容量被動(dòng)增大,符合SSCI后DSD的表現(xiàn)。由于SSCI后脊髓休克期,膀胱反射消失及尿潴留致使膀胱過(guò)度膨脹(bladder overdistension, BOD)[14]。損傷后急性期BOD使SSCI患者下尿路儲(chǔ)存功能惡化,并表現(xiàn)為最大膀胱壓力升高、膀胱順應(yīng)性降低[15-16]。有研究表明,LPP與膀胱順應(yīng)性呈負(fù)相關(guān)[17]。脊髓休克期后立即介入治療,電針組大鼠MCC、LPP明顯低于模型組(P<0.01),說(shuō)明電針治療對(duì)膀胱容量和壓力降低,減輕了損傷后急性期BOD,使膀胱保留了更多的順應(yīng)性,保護(hù)了SSCI后DSD大鼠的下尿路功能。
腎功能既受交感神經(jīng)的控制,又與腎臟微血管系統(tǒng)關(guān)系密切[18]。有研究認(rèn)為,脊髓橫斷后腎功能的改變可能由腎血流量和腎交感神經(jīng)活動(dòng)(renal sympathetic nerve activity, RSNA)的變化引起[19]。也有研究發(fā)現(xiàn),頸脊髓橫斷后有腎神經(jīng)和無(wú)腎神經(jīng)的大鼠腎功能沒(méi)有差異[20]。而腎血流量的減少將導(dǎo)致腎功能惡化[21]。SCI后腎臟微血管血流(microvascular blood flow, MVBF)逐漸下降,可能與尿潴留引起的腎血流阻力增加有關(guān)[22]。既往研究認(rèn)為,下尿路功能障礙與上尿路各種并發(fā)癥的發(fā)生關(guān)系密切,LPP和MCC值對(duì)發(fā)現(xiàn)上尿路損傷風(fēng)險(xiǎn)具有重要意義[23]。由此可見,電針治療可能通過(guò)降低SSCI后DSD大鼠膀胱容量和壓力,改善腎臟MVBF,發(fā)揮腎功能保護(hù)作用。
儲(chǔ)尿期的低順應(yīng)性膀胱和/或DO伴DSD引起的逼尿肌壓力過(guò)高,可能導(dǎo)致下、上尿路結(jié)構(gòu)的不可逆改變[24]。大鼠L6和S1的腹根和背根被橫切,4個(gè)月后大鼠膀胱內(nèi)壓、MCC、殘余尿量、膀胱順應(yīng)性、SCR及BUN均大于正常大鼠,并伴腎積水、膀胱和腎臟的纖維化,說(shuō)明大鼠神經(jīng)源性膀胱功能障礙與上尿路損傷之間的關(guān)系[25]。結(jié)合本研究結(jié)果可知:電針治療可減少腎小管壞死和細(xì)胞胞質(zhì)空泡化,減輕炎性細(xì)胞浸潤(rùn),減少腎組織結(jié)構(gòu)損傷;電針組大鼠BUN和SCR的表達(dá)低于模型組而高于空白組。進(jìn)一步證實(shí),電針刺激SSCI后DSD大鼠“中極”“次髎”“三陰交”穴通過(guò)降低膀胱MCC和LPP,而減少腎組織結(jié)構(gòu)損傷、保護(hù)腎功能的可能性。
脊髓完整的大鼠在膀胱充盈到出現(xiàn)收縮峰值時(shí)尿道外括約?。╡xternal urethral sphincter, EUS)同時(shí)舒張,SSCI誘導(dǎo)的DSD即逼尿肌和EUS的不協(xié)調(diào)。與人類在排尿過(guò)程中EUS全程舒張不同,大鼠EUS呈現(xiàn)節(jié)律性收縮和舒張,這種EUS爆發(fā)性松弛模式依靠反射調(diào)控。T10全橫斷大鼠面臨的是逼尿肌-EUS協(xié)調(diào)永久喪失。SSCI后,大鼠仍可通過(guò)EUS階段性爆發(fā)活動(dòng)排出尿液[26]。由此可見,反射性EUS爆發(fā)模式,是大鼠在SSCI導(dǎo)致失去脊髓上控制后也能部分實(shí)現(xiàn)有效排尿的重要原因。
正常情況下腎血流是自動(dòng)調(diào)節(jié)的,腎神經(jīng)作為中樞神經(jīng)系統(tǒng)和腎臟之間的聯(lián)系,只在異常情況下參與腎循環(huán)的控制[27]。SCI導(dǎo)致脊髓來(lái)源的交感神經(jīng)活動(dòng)抑制不足,使大鼠RSNA升高[28]。RSNA過(guò)度活躍和去甲腎上腺素水平升高,是腎臟疾病進(jìn)展的關(guān)鍵因素[29]。關(guān)于下胸椎和上腰椎交感神經(jīng)節(jié)前神經(jīng)元的研究表明,這些神經(jīng)元調(diào)節(jié)盆腔臟器并沒(méi)受到脊髓損傷的嚴(yán)重影響,脊髓中間神經(jīng)元似乎為這些神經(jīng)元提供了大部分的突觸輸入,并不依賴于大腦中樞控制的直接輸入,針對(duì)這些神經(jīng)元的治療應(yīng)該有助于交感神經(jīng)介導(dǎo)的盆腔內(nèi)臟反射的正?;痆30]。SCI后立即啟動(dòng)骶神經(jīng)調(diào)節(jié)(sacral neuromodulation, SNM),可以防止神經(jīng)源性逼尿肌過(guò)度活動(dòng)并保持膀胱容量和順應(yīng)性[31]。“次髎”位于骶尾部第2骶后孔處,八髎穴之一,屬膀胱經(jīng),臨近骶部脊髓排尿中樞,其下有支配膀胱等盆腔臟器的骶神經(jīng)S2~S4走行[32]。故電針“次髎”穴可能通過(guò)傳入刺激,調(diào)節(jié)交感、副交感傳出而影響排尿?!叭幗弧睘樽闾幤⒔?jīng)、足少陰腎經(jīng)和足厥陰肝經(jīng)交會(huì)穴,其下脛神經(jīng)通過(guò)。脛神經(jīng)傳入投射到L5~S1脊柱節(jié)段,可抑制膀胱過(guò)度活動(dòng)。與SNM對(duì)骶髓調(diào)節(jié)不同,脛神經(jīng)調(diào)節(jié)取決于對(duì)腰椎的傳入投射。電針刺激“三陰交”穴改善SSCI后DSD大鼠排尿功能,其治療機(jī)制可能除了與抑制排尿反射相關(guān)[33],還可能與脛神經(jīng)傳入促進(jìn)EUS爆發(fā)活動(dòng)恢復(fù)相關(guān)[34]。此外,“中極”位于下腹部正中線上,是膀胱的募穴,屬任脈。電刺激“中極”穴引起的腹壁收縮,導(dǎo)致腹內(nèi)壓力增加,有助于有效排空膀胱[35]。
電針刺激SSCI后DSD大鼠“次髎”“三陰交”“中極”穴,可能通過(guò)骶神經(jīng)、脛神經(jīng)傳入促進(jìn)EUS階段性爆發(fā)恢復(fù),調(diào)節(jié)交感、副交感傳出,提高排尿效率、降低膀胱MCC和LPP,進(jìn)而改善腎臟MVBF,發(fā)揮腎功能保護(hù)效應(yīng)。BUN和SCR的降低,腎組織結(jié)構(gòu)損傷的減少,均說(shuō)明電針治療可以通過(guò)改善下尿路功能阻止SSCI早期的腎功能損害。
參考文獻(xiàn)
[1] HOU S P, RABCHEVSKY A G. Autonomic consequences of spinal cord injury[J]. Comprehensive Physiology, 2014, 4(4): 1419-1453.
[2] HAMID R, AVERBECK M A, CHIANG H, et al. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury[J]. World Journal of Urology, 2018, 36(10): 1517-1527.
[3] STOFFEL J T. Detrusor sphincter dyssynergia: A review of physiology, diagnosis, and treatment strategies[J]. Translational Andrology and Urology, 2016, 5(1): 127-135.
[4] MANACK A, MOTSKO S P, HAAG-MOLKENTELLER C, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database[J]. Neurourology and Urodynamics, 2011, 30(3): 395-401.
[5] NSEYO U, SANTIAGO-LASTRA Y. Long-term complications of the neurogenic bladder[J]. The Urologic Clinics of North America, 2017, 44(3): 355-366.
[6] FAN Q, CAVUS O, XIONG L, et al. Spinal cord injury: How could acupuncture help?[J]. Journal of Acupuncture and Meridian Studies, 2018, 11(4): 124-132.
[7] 許 ?明,張 ?泓,劉繼生,等.完全性骶上脊髓損傷后神經(jīng)源性膀胱大鼠模型的建立及尿流動(dòng)力學(xué)分析[J].中國(guó)康復(fù)理論與實(shí)踐,2016,
22(8):869-875.
[8] 張雨辰,張 ?泓,艾 ?坤,等.大鼠脊髓損傷后神經(jīng)源性膀胱模型的制備[J].中國(guó)康復(fù)醫(yī)學(xué)雜志,2014,29(6):542-546.
[9] 陳向榮,游思維,金大地.BBB評(píng)分評(píng)估脊髓損傷大鼠后肢運(yùn)動(dòng)功能的探討[J].中國(guó)脊柱脊髓雜志,2004,14(9):547-549.
[10] 余曙光,徐 ?斌.實(shí)驗(yàn)針灸學(xué)[M].2版.北京:人民衛(wèi)生出版社, 2016.
[11] WOOLF A S, LOPES F M, RANJZAD P, et al. Congenital disorders of the human urinary tract: Recent insights from genetic and molecular studies[J]. Frontiers in Pediatrics, 2019, 7: 136.
[12] ISHIDA H, YAMAUCHI H, ITO H, et al. α1D-Adrenoceptor blockade increases voiding efficiency by improving external urethral sphincter activity in rats with spinal cord injury[J]. Regulatory, Integrative and Comparative Physiology, 2016, 311(5): R971-R978.
[13] HU H Z, GRANGER N, JEFFERY N D. Pathophysiology, clinical importance, and management of neurogenic lower urinary tract dysfunction caused by suprasacral spinal cord injury[J]. Journal of Veterinary Internal Medicine, 2016, 30(5): 1575-1588.
[14] JOELSSON-ALM E, NYMAN C R, SVENS?魪N C, et al. Micturition problems after bladder distension during hospitalization in Sweden: I'm not ill, just damaged for the rest of my life[J]. Nursing Research, 2014, 63(6): 418-425.
[15] WADA N, SHIMIZU T, SHUN T K, et al. Post-injury bladder management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury[J]. Neurourology and Urodynamics, 2017, 36(5): 1301-1305.
[16] TAKAHASHI R, KIMOTO Y, MAKI T, et al. Postinjury bladder overdistension deteriorates the lower urinary tract's storage function in patients with spinal cord injury[J]. Urologia Internationalis, 2020, 104(7/8): 604-609.
[17] GHONIEM G M, ROACH M B, LEWIS V H, et al. The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients[J]. The Journal of Urology, 1990, 144(6): 1440-1442.
[18] KRISHNAN S, SUAREZ-MARTINEZ A D, BAGHER P, et al. Microvascular dysfunction and kidney disease: Challenges and opportunities?[J]. Microcirculation, 2021, 28(3): e12661.
[19] OSBORN J W J, LIVINGSTONE R H, SCHRAMM L P. Elevated renal nerve activity after spinal transection: Effects on renal function[J]. The American Journal of Physiology, 1987, 253(4 Pt 2): R619-R625.
[20] TROSTEL K A, OSBORN J W. Do renal nerves chronically influence renal function and arterial pressure in spinal rats?[J]. The American Journal of Physiology, 1992, 263(6 Pt 2): R1265-R1270.
[21] CZARKOWSKA-PCZEK B, MUCHA K, PCZEK L. Age-related decline in renal blood flow could be a beneficial and compensatory mechanism[J]. Medical Science Monitor, 2020, 26: e918643.
[22] YUAN X, WU Q, TANG Y, et al. Systemic microcirculation dysfunction after low thoracic spinal cord injury in mice[J]. Life Sciences, 2019, 221: 47-55.
[23] MOSLAVAC S, DZIDIC I, KEJLA Z. Neurogenic detrusor overactivity: Comparison between complete and incomplete spinal cord injury patients[J]. Neurourology and Urodynamics, 2008, 27(6): 504-506.
[24] BYWATER M, TORNIC J, MEHNERT U, et al. Detrusor acontractility after acute spinal cord injury—Myth or reality?[J]. The Journal of Urology, 2018, 199(6): 1565-1570.
[25] LI Y L, WEN J J, WEN Y B, et al. Reconstruction of bladder function and prevention of renal deterioration by means of end-to-side neurorrhaphy in rats with neurogenic bladder[J]. Neurourology and Urodynamics, 2018, 37(4): 1272-1280.
[26] KADEKAWA K, YOSHIMURA N, MAJIMA T, et al. Characterization of bladder and external urethral activity in mice with or without spinal cord injury: A comparison study with rats[J]. Regulatory, Integrative and Comparative Physiology, 2016, 310(8): R752-R758.
[27] ZANCHETTI A, STELLA A. Sympatho-renal interactions[J]. The Italian Journal of Neurological Sciences, 1987, 8(5): 477-485.
[28] ZAHNER M R, KULIKOWICZ E, SCHRAMM L P. Recovery of baroreflex control of renal sympathetic nerve activity after spinal lesions in the rat[J]. Regulatory, Integrative and Comparative Physiology, 2011, 301(5): R1584-R1590.
[29] NOH M R, JANG H S, KIM J, et al. Renal sympathetic nerve-derived signaling in acute and chronic kidney diseases[J]. International Journal of Molecular Sciences, 2020, 21(5): 1647.
[30] LLEWELLYN-SMITH I J, WEAVER L C, KEAST J R. Effects of spinal cord injury on synaptic inputs to sympathetic preganglionic neurons[J]. Progress in Brain Research, 2006, 152: 11-26.
[31] REDSHAW J D, LENHERR S M, ELLIOTT S P, et al. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury[J]. BMC Urology, 2018, 18(1): 72.
[32] LEE C L, LEE J, PARK J M, et al. Sophisticated regulation of micturition: Review of basic neurourology[J]. Journal of Exercise Rehabilitation, 2021, 17(5): 295-307.
[33] MATSUTA Y, ROPPOLO J R, DE GROAT W C, et al. Poststimulation inhibition of the micturition reflex induced by tibial nerve stimulation in rats[J]. Physiological Reports, 2014, 2(1): e00205.
[34] 劉黎黎,董熙遠(yuǎn),陳 ?彪.電針刺激三陰交穴對(duì)壓力性尿失禁大鼠脊髓NMDA受體及α 2受體表達(dá)的影響[J].中華物理醫(yī)學(xué)與康復(fù)雜志,2021,43(3):206-210.
[35] CRUZ Y, DOWNIE J W. Abdominal muscle activity during voiding in female rats with normal or irritated bladder[J]. Regulatory, Integrative and Comparative Physiology, 2006, 290(5): R1436-R1445.
〔收稿日期〕2022-07-04
〔基金項(xiàng)目〕國(guó)家自然科學(xué)基金面上項(xiàng)目(81874510);國(guó)家自然科學(xué)基金青年項(xiàng)目(82205255);湖南省自然科學(xué)基金青年項(xiàng)目(82019JJ50437,
2022JJ40312);湖南省大學(xué)生創(chuàng)新創(chuàng)業(yè)訓(xùn)練計(jì)劃項(xiàng)目(S202110541019);湖南省教育廳科研項(xiàng)目(20C1432)。
〔第一作者〕張雨辰,女,博士研究生,研究方向:常見疾病針灸康復(fù)機(jī)制的研究。
〔通信作者〕*張 ?泓,男,教授,博士研究生導(dǎo)師,E-mail:zh5381271@sina.com;艾 ?坤,男,副教授,碩士研究生導(dǎo)師,E-mail:aikun650@qq.com。
湖南中醫(yī)藥大學(xué)學(xué)報(bào)2023年3期